NCT04437966

Brief Summary

In Barbados, levels of hypertension are high (40.7%) and cause of a high proportion of deaths due to cardiovascular diseases. In this study, the Stanford University-led Chronic Disease Self-Management Program (CDSMP) will be modified to form one of the basic components of a three-pronged intervention to improve blood pressure control. Our overall goal is to evaluate the effectiveness of a hypertension self-management program in community-based settings. With the advent of the Coronavirus disease 2019 (COVID-19) we recognize that it may be necessary to adapt the programme to accommodate virtual delivery. Our specific aims are to:

  1. 1.Adapt the Stanford (CDSMP) to ensure cultural appropriateness to Barbados. In view of the need to adhere to physical distance guidelines in the era of COVID-19 disease, modifications will be made to enhance virtual delivery while maintaining programme fidelity. We will engage stakeholders in performing modifications related to content, context and mode of delivery of the CDSMP program with the goal of ensuring cultural appropriateness.
  2. 2.Determine the clinical effectiveness of CDSMP combined with medication enhancement tools. We will conduct a cluster randomized trial in twelve faith-based organizations(FBOs) in Barbados. We are primarily interested in studying the changes in systolic blood pressure. Secondarily, we will also assess change in weight, medication adherence, dietary behavior and physical activity.
  3. 3.Understand the barriers and facilitators to implementation and sustainability of CDSMP plus self-monitoring tools in faith-based organizations. We will assess cost and sustainability of the intervention and qualitatively assess factors associated with barriers and facilitators of implementation in FBOs in Barbados.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
384

participants targeted

Target at P75+ for not_applicable hypertension

Timeline
Completed

Started Oct 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 11, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 18, 2020

Completed
4 months until next milestone

Study Start

First participant enrolled

October 11, 2020

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

June 24, 2021

Status Verified

June 1, 2021

Enrollment Period

12 months

First QC Date

June 11, 2020

Last Update Submit

June 20, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Systolic blood pressure

    We will measure systolic blood pressure before and 6 months after the interventions

    Six months

Secondary Outcomes (4)

  • Mean weight change for intervention and control groups

    Six months

  • Level of adherence to the Dietary Approaches to Stop Hypertension (DASH) Diet

    Six months

  • Assessing physical activity levels using the Global Physical Activity Questionnaire (GPAQ)

    Six months

  • Self-Efficacy for Managing Chronic Diseases 6-item Scale

    Six months

Study Arms (2)

Self-management Group

EXPERIMENTAL

The intervention consists of three levels - (1) chronic disease self-management workshops, (2) distribution of and teaching on the use of medication pill boxes and (3) use of social media (WhatsApp version 2.0) to encourage medication adherence. We combine the Stanford Chronic Disease Self-Management Curriculum, add medication adherence tools and social media use to develop a novel intervention aimed at better blood pressure control. The CDSMP focuses on enhancing skills through problem solving and brainstorming activities. In the workshop we discuss: blood pressure control, finding and affording healthy foods, label reading, physical activity, planning a healthy plate, making traditional foods healthy and portion control. Pill boxes will be distributed to all individuals in the intervention group. Post workshop, participants will be sent twice weekly reminders to use their high blood pressure medications via the social media tool WhatsApp. These will be sent for one month.

Behavioral: Enhanced Chronic Disease Self-management program

Usual care group

NO INTERVENTION

Controls will receive educational material at baseline and one didactic session (on importance of medication adherence to hypertension control) lasting 1 hour delivered by a health care professional.

Interventions

CDSMP workshops will last for approximately 2.5 hours and occur weekly for six weeks. Sessions will focus on appropriate diet for persons with hypertension and to facilitate weight loss; managing medications, adherence to medical clinic appointments; physical activity and stress management. Participants make weekly action plans, share experiences, and help each other solve problems they encounter in creating and carrying out their self-management program. Participants will also be given pill boxes and will be prompted by social media messages to make and keep clinic appointments as well as maintain a healthy lifestyle.

Self-management Group

Eligibility Criteria

Age35 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Resident in Barbados for the previous six months
  • No plans to migrate over the ensuing one year.
  • All persons with a previous diagnosis of hypertension or currently on anti- hypertensives AND the occurrence of two or more blood pressure readings above 140 mmHg (systolic) or 90mmHg (diastolic) on the day of recruitment will be deemed eligible.
  • Persons not known to have hypertension but who have two or more blood pressure readings above 140 mmHg (systolic) or 90mmHg (diastolic) on the day of recruitment are also eligible

You may not qualify if:

  • Non-residents of Barbados
  • Persons whose systolic blood pressure is below 140mmHg AND/OR diastolic blood pressure below 90mmHg
  • Persons who are pregnant of planning to become pregnant over the following nine months
  • Unwillingness/inability to comply with the study protocol
  • Current participation in another study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

George Alleyne Chronic Disease Research Centre

Bridgetown, BB15000, Barbados

RECRUITING

Related Publications (1)

  • Sobers NP, Hambleton IR, Hassan S, Anderson SG, Brathwaite-Graham L, Lewis K, Ferguson TS. Assessing the effectiveness and implementation of a chronic disease self-management programme in faith-based organisations in Barbados: protocol for a cluster randomised parallel trial. BMJ Open. 2021 Oct 4;11(10):e050548. doi: 10.1136/bmjopen-2021-050548.

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • Natasha P Sobers, PhD

    George Alleyne Chronic Disease Research Centre

    PRINCIPAL INVESTIGATOR
  • Lisa Brathwaite-Graham, MPH

    George Alleyne Chronic Disease Research Centre

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Data collectors will be blinded to church randomization status until the end of the six-week recruitment period.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Twelve faith based organizations will be chosen from an organization known as New Testament Church of God Assemblies (a Pentecostal religion). Of the 12 organizations selected to participate in the study, six will be randomized to receive the intervention and six will receive usual care. the study statistician will randomly assign each church to either intervention or control groups based on a 1:1 ratio, using a pre-specified random number generator (Stata statistical software version 16). Using a 3-church block, we will assign 2 churches to intervention and 2 churches to control in each randomization block. Block randomization will be used to ensure balanced distribution of intervention and control churches.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer, Epidemiology

Study Record Dates

First Submitted

June 11, 2020

First Posted

June 18, 2020

Study Start

October 11, 2020

Primary Completion

October 1, 2021

Study Completion

December 1, 2021

Last Updated

June 24, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will share

De-identified individual participant data (IPD) will be shared, with standard removal of identifiable information (list the variables) and with de-identification of all dates by random shifting. All IPD that underlie results in a publication will be shared.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
The data will become available two years after the study analysis is complete.
Access Criteria
IPD will only be shared if the absolute number of participants is greater than 20. There will be grouping of variables (such as exact age) that may contribute to "potential identifiability" of participants. Researchers will be given the option of contact with PI to use original dataset for approved research purposes.

Locations